[CLDX] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 5.39%
YoY- -3.95%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 4,131 1,517 268 967 1,613 407 163 757.73%
PBT -43,306 -38,260 -30,502 -29,361 -26,487 -26,784 -36,004 13.06%
Tax 13,384 -2,979 -3,459 -6,946 -2,796 -912 16,564 -13.21%
NP -43,306 -38,260 -30,502 -22,415 -23,691 -26,784 -52,568 -12.09%
Tax Rate - - - - - - - -
Total Cost 47,437 39,777 30,770 23,382 25,304 27,191 52,731 -6.79%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -1,048.32 -2,522.08 -11,381.34 -2,317.99 -1,468.75 -6,580.84 -32,250.31 -89.75%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.83 -0.81 -0.65 -0.47 -0.50 -0.57 -1.12 -18.06%
EPS Diluted -0.83 -0.81 -0.65 -0.47 -0.50 -0.57 -1.12 -18.06%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.